Funding

Mithrl

United States · AI · Biotech

Mithrl builds a scientific decision engine for biopharma and research teams. Its biomedical world model combines validated biological knowledge with each organization’s data, then uses AI agents and workflows to help scientists analyze experiments, assess hypotheses and accelerate drug-discovery decisions; the company is preparing its next-generation platform for broader deployment.

Visit mithrl.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series A$20MObvious Ventures — LeadAGI House — ParticipantHeadline — Participant

Investors

Obvious VenturesLed Series AAGI HouseJoined Series AHeadlineJoined Series A

Coverage

Sep 16, 2026Mithrl · Series A

Similar companies

Fairy DevicesTokyo company developing wearable devices and remote-assistance software for industrial field workers.Undisclosed · JICN equity investment
Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Knowledge WorkTokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.¥4.8B · Series C debt second close
Sourcesmithrl.com ↗mithrl.com ↗finsmes.com ↗